PREVENT trial; Preventive PCI versus OMT for plaques

Marc Bonaca at the ACC24

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Beneficial effects of GLP-1RA in patients with obesity-related HFpEF and T2D
Beneficial effects of GLP-1RA in patients with obesity-related HFpEF and T2D
ACC.24
Beneficial effects of GLP-1RA in patients with obesity-related HFpEF and T2D
- Mikhail Kosiborod, MD
Effects of aldose reductase inhibitor on exercise capacity in diabetic cardiomyopathy
Effects of aldose reductase inhibitor on exercise capacity in diabetic cardiomyopathy
ACC.24
Effects of aldose reductase inhibitor on exercise capacity in diabetic cardiomyopathy
- James Januzzi, MD
Promising results for self-expanding TAVR device in trial with mostly women
Promising results for self-expanding TAVR device in trial with mostly women
ACC.24
Promising results for self-expanding TAVR device in trial with mostly women
- Hadley Wilson, MD
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
ACC.24
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
- Akshay S. Desai, MD